2 completed, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Unknown 1 |
Follow poly ICLC: new trials by email Literature Review of poly ICLC trials Research Report on poly ICLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients NeoPep Vaccine1 plus Poly-ICLC, NeoPep Vaccine2 plus Poly-ICLC - Glioma, Malignant, Antigen-specific Vaccines | Not applicable | Unknown | Shanghai 10th People's Hospital | 10 | 2022-09-13 | 2022-10-12 |
| Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen Poly ICLC, Poly I:C, R848 - Allergic Rhinitis, Asthma | Not applicable | Completed | Imperial College London | 93 | 2014-03-01 | 2021-11-05 |
| PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment Peptide Vaccine, Poly IC-LC - Prostate Cancer | Not applicable | Completed | H. Lee Moffitt Cancer Center and Research Institute | 29 | 2008-12-02 | 2019-10-04 |
Asthma (1) · Glioma (1) · Hypersensitivity (1) · Inflammation (1) · Latent Tuberculosis (1) · Prostatic Neoplasms (1) · Respiratory Tract Infections (1) · Rhinitis, Allergic (1) · Rhinitis, Allergic, Seasonal (1) · Tuberculosis (1) · Virus Diseases (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · Imperial College London (1) · Shanghai 10th People's Hospital (1)
China (1) · Puerto Rico (1) · United Kingdom (1) · United States (1)
Liang Gao, Phd (1) · Mayer Fishman, M.D., Ph.D. (1) · Peter JM Openshaw, FRCP, PhD, FRSB, FMedSci (1) · Robin Shattock, PhD (1) · Trevor Hansel, FRCPath, PhD (1)